SRT2379
End of the line for GSK’s resveratrol
January 14, 2011Research and Development GSK, GlaxoSmithKline, SRT2104, SRT2379, SRT501, Sirtris, multiple myeloma, resveratrol
GlaxoSmithKline is halting all work on resveratrol, a compound found in red wine and thought to have life extending properties. …
Latest content
Highlighting the value of lab research for healthcare innovation
November 2, 2026
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
